Clinical Trials · NCT03011021
Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes
- Phase
- Phase 1/Phase 2
- Recruitment status
- Unknown
- Sponsor
- Second Xiangya Hospital of Central South University
- Enrollment
- 40
- Start date
- Jan 2017
- Locations
- 1 site, China
- Primary endpoint
- Adverse effects